PhDr. Karel Hejduk
Researcher, Institute of Biostatistics and Analyses
correspondence Address:
Kamenice 753/5, 625 00 Brno
office: 354
Poštovská 68/3
602 00 Brno
phone: | +420 549 49 7246 |
---|---|
e‑mail: |
Total number of publications: 202
2021
-
The Czech National Programme for Early Detection of Chronic Obstructive Pulmonary Disease – interim results from the pivotal project
Year: 2021, type: Conference abstract
2020
-
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE
DRUG SAFETY, year: 2020, volume: 43, edition: 10, DOI
-
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society
Biomedical Papers, year: 2020, volume: 164, edition: 4, DOI
-
Indikátory kvality onkologických screeningových programů nová data o intervalových karcinomech
Year: 2020, type: Conference abstract
-
MAMES – Monitoring, analýza a management epidemických situací: Popis algoritmizace a implementace epidemických modelů a mapování kapacit
Year: 2020, type:
-
Náklady na léčbu kolorektálního karcinomu a nákladová efektivita screeningového programu v České republice
Year: 2020, type: Conference abstract
-
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis
RESPIRATORY RESEARCH, year: 2020, volume: 21, edition: 1, DOI
2019
-
Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease
Frontiers in Pharmacology, year: 2019, volume: 10, edition: 241, DOI
-
Časný záchyt CHOPN – pilotní projekt ÚZIS ČR a ČPFS ČLS JEP
Year: 2019, type: Appeared in Conference without Proceedings
-
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease
ADVANCES IN THERAPY, year: 2019, volume: 36, edition: 5, DOI